Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Glucose Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02512068
What this trial is testing

A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 107
Post-approval studies (Phase 4)Study completedNCT00845182
What this trial is testing

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

Who this might be right for
Type 2 DiabetesHealthyImpaired Glucose Tolerance
The University of Texas Health Science Center at San Antonio 43
Not applicableNot Yet RecruitingNCT07642518
What this trial is testing

Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive Impairment

Who this might be right for
Type 2 DiabetesMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 38
Not applicableUnknownNCT00472342
What this trial is testing

The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients

Who this might be right for
Impaired Glucose ToleranceDiabetes
Yonsei University 182
Not applicableNot Yet RecruitingNCT06767124
What this trial is testing

Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment and Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease and Related Dementias (ADRD)
University of Pennsylvania 17
Not applicableNot Yet RecruitingNCT06704542
What this trial is testing

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONDiabetes MellitusImpaired Fasting Glucose
Ruijin Hospital 1,000
Not applicableUnknownNCT00417950
What this trial is testing

Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes

Who this might be right for
Diabetes MellitusImpaired Glucose Tolerance
Taichung Veterans General Hospital 30
Not applicableStudy completedNCT01375959
What this trial is testing

Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
Albert Einstein College of Medicine 38
Not applicableStudy completedNCT00381186
What this trial is testing

Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study

Who this might be right for
Impaired Glucose ToleranceType 2 Diabetes
Maastricht University Medical Center 150
Large-scale testing (Phase 3)Study completedNCT00489229
What this trial is testing

To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

Who this might be right for
DiabetesImpaired Glucose Tolerance
Universiti Sains Malaysia 66
Not applicableStudy completedNCT00470262
What this trial is testing

Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

Who this might be right for
Metabolic Syndrome XPrediabetic State
VA Office of Research and Development 27
Large-scale testing (Phase 3)Ended earlyNCT00958269
What this trial is testing

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Phenomix 360
Not applicableStudy completedNCT04825366
What this trial is testing

Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training

Who this might be right for
Type 1 DiabetesHypoglycemia Unawareness
Institut de Recherches Cliniques de Montreal 47
Not applicableStudy completedNCT00943787
What this trial is testing

Counter-Regulatory Impairment and the Effect of Microvascular Insulin Transfer in Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
University of Virginia 41
Not applicableStudy completedNCT02455934
What this trial is testing

Effects of D-allulose (Psicose) With Sucrose Beverage on Glucose Tolerance and Insulin Level

Who this might be right for
Impaired Glucose Tolerance
Chiang Mai University 30
Not applicableStudy completedNCT00941954
What this trial is testing

Walking Away: Structured Education Versus Written Information for Individuals With High Risk of Developing Type 2 Diabetes

Who this might be right for
Diabetes
University Hospitals, Leicester 833
Testing effectiveness (Phase 2)Study completedNCT04727580
What this trial is testing

HSK7653 in Chinese Patients with Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
Haisco Pharmaceutical Group Co., Ltd. 99
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Early research (Phase 1)Study completedNCT01069926
What this trial is testing

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

Who this might be right for
Glucose Lowering
AstraZeneca 21
Early research (Phase 1)Study completedNCT00572650
What this trial is testing

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Who this might be right for
Type 2 Diabetes Mellitus
Novartis 29
Next Page